- FDA OKs New Keytruda Shot for Cancer The New York Times
- FDA Approves Subcutaneous Pembrolizumab for Solid Tumors OncLive
- Merck wins approval of subcutaneous Keytruda, in bid to extend life of world’s top-selling drug Endpoints News
- Merck Wins US Approval of Easier-to-Use Version of Cancer Drug Keytruda Bloomberg.com
- US FDA approves Merck’s injectable version of blockbuster cancer therapy Keytruda Reuters
Source link
